If you are having trouble viewing this email, please view it on our website.

         
 
A Service Announcement from Pharmexec
  Pharmaceutical Executive  
     
 

f

 
 
The Healthcare business of Thomson Reuters
 

“When my company turned to me for opportunities in a new therapy class, I turned to Thomson Reuters Pharma™.”

It’s important to have a broad base of knowledge — especially when researching the pipelines, partnerships, and promise of a narrow therapy area. With quick access to accurate, up-to-the-minute information on pipeline drugs, their market potential, and the companies and deals making headway in that area, you can confidently recommend the best opportunities for your company.

See a live demonstration of Thomson Reuters Pharma — the comprehensive source trusted by 100 percent of the top 20 pharmaceutical companies.

 

SEE IT FOR YOURSELF

See why 100 percent of the top 20 pharmaceutical companies trust Thomson Reuters Pharma.

Sign up for a live
demonstration with one of
our representatives. Visit

go.thomsonreuters.com/bdl.

d

1500 Spring Garden Street, Fourth Floor, Philadelphia, PA 19130 USA
77 Hatton Garden, London EC1N 8JS, UK
Palaceside Bldg. 5F, 1-1-1 Hitotsubashi, Chiyoda-ku, Tokyo 100-0003 Japan
18 Science Park Drive,Singapore 118229
To ensure our emails reach your inbox, please add us to your address book.
Copyright © 2010
Thomson Reuters


 


If you no longer wish to receive emails from Thomson Reuters, Please click here.

Pharmaceutical Executive is published by Advanstar Communications, 485 Rt 1 South, Iselin, NJ
This is an advertisement sent on behalf of this advertiser.